White label – Pompe disease - ClinicalTrials.eu

Study on Upadacitinib for Pain Management in Patients with Psoriatic Arthritis

Not recruiting

3 1 1 1
Investigated Diseases:
- Psoriatic arthropathy
Investigated Drugs:
- Upadacitinib
Comparing Methotrexate and Tocilizumab for Treating Giant Cell Arteritis in Patients: A Study on Effectiveness and Safety

Not recruiting

3 1 1 1
Investigated Diseases:
- Giant cell arteritis
Investigated Drugs:
Study on Alpelisib with Fulvestrant or Letrozole for Patients with Advanced Breast Cancer and PIK3CA Mutation After Previous Treatments

Not recruiting

2 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
Study of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Renal cell carcinoma
Investigated Drugs:
+7
Study Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma refractory
- Plasma cell myeloma
Investigated Drugs:
+4
Study on the Safety of Allocetra for Patients with Knee Osteoarthritis

Not recruiting

1 1
Investigated Diseases:
- Osteoarthritis
Investigated Drugs:
- Allogeneic Peripheral Blood Mononuclear Cells Induced To An Early Apoptotic State
Study Comparing Cisplatin and Radiotherapy with Durvalumab and Radiotherapy for Patients with Intermediate Risk HPV-Positive Oropharyngeal Cancer

Not recruiting

2 1 1 1
Investigated Drugs:
- Cisplatin
- Durvalumab
Study on Lidocaine, Ropivacaine, and Epinephrine for Patients Undergoing Hand Surgery with Ultrasound-Guided Nerve Block

Not recruiting

3 1 1 1
Investigated Drugs:
Study of Pembrolizumab, Carboplatin, and Paclitaxel for Patients with Metastatic Squamous Non-small Cell Lung Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Squamous cell carcinoma of lung
Investigated Drugs:
Study of Pembrolizumab, Favezelimab, and Lenvatinib for Patients with Advanced Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer stage IV
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies